Comparison of Three Commercial Molecular Assays for Detection of Rifampin and Isoniazid Resistance among Mycobacterium tuberculosis Isolates in a High-HIV-Prevalence Setting

J Clin Microbiol. 2015 Sep;53(9):3032-4. doi: 10.1128/JCM.01691-15. Epub 2015 Jul 1.

Abstract

In a head-to-head comparison of the MTBDRplus version 2.0 (Hain Lifescience), the Xpert MTB/RIF (Cepheid), and the Anyplex MTB/NTM (Seegene) assays, we demonstrated equal sensitivity (59/61; 96.7%) and specificity (53/54; 98.1%) for detecting rifampin resistance with further analysis of discordances. The Xpert assay does not detect isoniazid resistance while the Anyplex assay showed high false positivity.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Drug Resistance, Bacterial*
  • Genotyping Techniques / methods*
  • HIV Infections / complications
  • HIV Infections / epidemiology
  • Humans
  • Isoniazid / pharmacology*
  • Microbial Sensitivity Tests / methods
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / isolation & purification
  • Rifampin / pharmacology*
  • Sensitivity and Specificity
  • Tuberculosis / microbiology

Substances

  • Antitubercular Agents
  • Isoniazid
  • Rifampin